Allonca Campa, Eva

Astudillo González, María Aurora

Balbín Felechosa, Milagros

García Carracedo, Dario

García Pedrero, Juana María

González Meana, María Victoria

Martínez Camblor, Pablo

Rodrigo Tapia, Juan Pablo

Santamaría Ruiz de Azúa, Íñigo

Suárez Fernández, Laura

Villaronga Torres, María de los Ángeles

Álvarez Teijeiro, Saúl

This study was supported by grants from the Plan Nacional de I+D+I 2008-2011 Instituto de Salud Carlos III (PI11/00929 to JPR) and Plan Nacional de I+D+I 2013-2016 ISCIII (CP13/00013 and PI13/00259 to JMGP),RD12/0036/0015 of Red Temática de Investigación Cooperativa en Cáncer (RTICC), Spain, and the FEDER Funding Program from the European Union. M.A.V. is recipient of a fellowship from ISCIII (CD13/00157). Work in the laboratory of G.S. was funded by grant NIH R01CA109525García-Carracedo, D., Ángeles Villaronga, M., Álvarez-Teijeiro, S., Hermida-Prado, F., Santamaría, I., Allonca, E., Suárez-Fernández, L., Victoria Gonzalez, M., Milagros Balbín, M., Astudillo, A., Martínez-Camblor, P., Su, G.H., Rodrigo, J.P., García-Pedrero, J.M

Repositorio Institucional de la Universidad de Oviedo

Oncotarget

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

http://digibuo.uniovi.es/dspace/bitstream/10651/39672/1/Oncotarget.pdf

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

Abstract

Similar works

Full text

Available Versions

Repositorio Institucional de la Universidad de Oviedo